🇺🇸 FDA
Patent

US 12290597

Oral film compositions and dosage forms having precise active dissolution profiles

granted A61KA61K31/551A61K31/5513

Quick answer

US patent 12290597 (Oral film compositions and dosage forms having precise active dissolution profiles) held by Aquestive Therapeutics, Inc. expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aquestive Therapeutics, Inc.
Grant date
Tue May 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/551, A61K31/5513, A61K9/0056, A61K9/006